- Home
- DNN vs VERA Comparison
DNN vs VERA Comparison
Compare DNN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- VERA
- Stock Information
- Founded
- DNN 1954
- VERA 2016
- Country
- DNN Canada
- VERA United States
- Employees
- DNN N/A
- VERA N/A
- Industry
- DNN Other Metals and Minerals
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- VERA Health Care
- Exchange
- DNN Nasdaq
- VERA Nasdaq
- Market Cap
- DNN 1.8B
- VERA 1.7B
- IPO Year
- DNN 1997
- VERA 2021
- Fundamental
- Price
- DNN $2.85
- VERA $31.07
- Analyst Decision
- DNN Strong Buy
- VERA Buy
- Analyst Count
- DNN 1
- VERA 8
- Target Price
- DNN $2.75
- VERA $64.29
- AVG Volume (30 Days)
- DNN 98.5M
- VERA 1.5M
- Earning Date
- DNN 11-06-2025
- VERA 11-06-2025
- Dividend Yield
- DNN N/A
- VERA N/A
- EPS Growth
- DNN N/A
- VERA N/A
- EPS
- DNN N/A
- VERA N/A
- Revenue
- DNN $3,311,190.00
- VERA N/A
- Revenue This Year
- DNN $197.76
- VERA N/A
- Revenue Next Year
- DNN $54.87
- VERA N/A
- P/E Ratio
- DNN N/A
- VERA N/A
- Revenue Growth
- DNN 12.14
- VERA N/A
- 52 Week Low
- DNN $1.08
- VERA $18.53
- 52 Week High
- DNN $2.97
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- DNN 68.96
- VERA 79.29
- Support Level
- DNN $2.70
- VERA $28.48
- Resistance Level
- DNN $2.93
- VERA $29.97
- Average True Range (ATR)
- DNN 0.15
- VERA 1.39
- MACD
- DNN -0.01
- VERA 0.38
- Stochastic Oscillator
- DNN 75.00
- VERA 92.90
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.